PMID- 31467480
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220410
IS  - 1357-714X (Print)
IS  - 1369-1643 (Electronic)
IS  - 1357-714X (Linking)
VI  - 2019
DP  - 2019
TI  - A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity.
PG  - 8704936
LID - 10.1155/2019/8704936 [doi]
LID - 8704936
AB  - PURPOSE: Previous studies have grouped the treatment of axial and appendicular 
      synovial sarcomas. The purpose of this study was to assess the prognostic 
      variables of upper extremity synovial sarcomas (UESS) and compare the outcomes of 
      those who underwent a nononcologic or inadvertent excision prior to definitive 
      resection to those who underwent an initial oncologic resection. METHODS: We 
      reviewed the records of 23 UESS treated with definitive surgery at our 
      institution between 1990 and 2014. There were 13 women and 10 men with a median 
      age of 30 years (6-60) and median follow-up of 63 months (15-248). Prognostic 
      variables, recurrence-free survival (RFS), and overall survival (OS) were then 
      assessed. RESULTS: Fifteen patients (65%) had a prior unplanned excision. Five 
      patients required an amputation to obtain local control of disease. There were 3 
      observed local recurrences and 2 distant metastases at a median of 45 months from 
      presentation. We found no difference in need for amputation, RFS, or OS between 
      those who had undergone a planned excision and those who had an unplanned 
      excision. CONCLUSION: While we were unable to find a significant difference in 
      outcomes or amputation rates between those who underwent reexcision of a 
      previously unplanned excision and those who underwent an initial planned 
      resection, the high rate of unplanned excision is troubling and should remind 
      practitioners to consider sarcoma in the differential of all upper extremity 
      masses.
FAU - Post, J
AU  - Post J
AD  - Beacon Memorial Hospital, South Bend, IN, USA.
FAU - Houdek, M
AU  - Houdek M
AD  - Mayo Clinic, Rochester, MN, USA.
FAU - Folpe, A L
AU  - Folpe AL
AD  - Mayo Clinic, Rochester, MN, USA.
FAU - Kakar, S K
AU  - Kakar SK
AD  - Mayo Clinic, Rochester, MN, USA.
FAU - Wilke, B K
AU  - Wilke BK
AUID- ORCID: 0000-0002-3604-6954
AD  - Mayo Clinic, Jacksonville, FL, USA.
AD  - Beacon Memorial Hospital, South Bend, IN, USA.
LA  - eng
PT  - Journal Article
DEP - 20190801
PL  - Egypt
TA  - Sarcoma
JT  - Sarcoma
JID - 9709257
PMC - PMC6701306
COIS- The authors declare that there are no conflicts of interest regarding the 
      publication of this paper.
EDAT- 2019/08/31 06:00
MHDA- 2019/08/31 06:01
PMCR- 2019/08/01
CRDT- 2019/08/31 06:00
PHST- 2019/02/27 00:00 [received]
PHST- 2019/06/29 00:00 [revised]
PHST- 2019/07/14 00:00 [accepted]
PHST- 2019/08/31 06:00 [entrez]
PHST- 2019/08/31 06:00 [pubmed]
PHST- 2019/08/31 06:01 [medline]
PHST- 2019/08/01 00:00 [pmc-release]
AID - 10.1155/2019/8704936 [doi]
PST - epublish
SO  - Sarcoma. 2019 Aug 1;2019:8704936. doi: 10.1155/2019/8704936. eCollection 2019.